In 2023, the analgesic medicine sales in Germany stood at USD 40.1 PPP per capita. Forecasts from 2024 to 2028 show a consistent upward trend in sales: USD 42.8 PPP per capita in 2024, USD 45.3 in 2025, USD 47.8 in 2026, USD 50.3 in 2027, and USD 52.8 in 2028.
Year-on-year variations reveal a relatively steady growth pattern:
- 2024: 6.7%
- 2025: 5.8%
- 2026: 5.5%
- 2027: 5.2%
- 2028: 5.0%
The Compound Annual Growth Rate (CAGR) over this five-year period is approximately 5.6%.
Future trends to watch for include the potential impact of new regulatory policies, the emergence of alternative therapies, and advancements in pain management technologies. Additionally, demographic shifts such as an aging population could further influence the demand for analgesic medicines.
